Candidemia in Cancer Patients: A Prospective, Multicenter Surveillance Study by the Invasive Fungal Infection Group (IFIG) of the European Organization for Research and Treatment of Cancer (EORTC)
The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Abstract
In a surveillance study of candidemia in cancer patients that was conducted by the European Organization for Research and Treatment of Cancer, 249 episodes were noted; Candida albicans was isolated in 70% (63) of the 90 cases involving patients with solid tumors (tumor patients) and in 36% (58) of the 159 involving those with hematologic disease (hematology patients). Neutropenia in tumor patients and acute leukemia and antifungal prophylaxis in hematology patients were significantly associated with non-albicans candidemia in a multivariate analysis. Overall 30-day mortality was 39% (97 of 249). In a univariate analysis, Candida glabrata was associated with the highest mortality rate (odds ratio, 2.66). Two multivariate analyses showed that mortality was associated with older age and severity of the underlying disease. Among hematology patients, additional factors associated with mortality were allogeneic bone marrow transplantation, septic shock, and lack of antifungal prophylaxis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Previous studies also showed a significant association between receipt of antifungal prophylaxis as well as acute leukemia and a higher incidence of candidemia caused by Candida species other than C. albicans (41).”
In the citing paper
“In cancer patients, Viscoli et al. [18] also suggested that C. glabrata was associated with a higher mortality rate.”
From Management of invasive candidiasis and candidemia in adult non-neutropenic intensive care unit patients: part I. Epidemiology and diagnosis (2009) · cites this paper as [18]
In the citing paper
“Other North American and European investigators confirmed these observations in larger hospital settings [10, 11, 13, 20, 22, 25, 26].”
From Epidemiology of Candidemia in Swiss Tertiary Care Hospitals: Secular Trends, 1991–2000 (2004) · cites this paper as [11]
In the citing paper
“Candidemia due to C. parapsilosis has increased in frequency in pediatric populations and appears to be associated with a lower mortality rate than is candidemia due to other species of Candida [110-113].”
From Guidelines for Treatment of Candidiasis (2004) · cites this paper as [113]
In the citing paper
“Candidemia due to C. glabrata may be associated with increased mortality in patients with cancer [113].”
From Guidelines for Treatment of Candidiasis (2004) · cites this paper as [113]
Citations
Cites
Regression Models and Life-Tables
Cox, D. R. (1992) · Springer Series in Statistics · doi:10.1007/978-1-4612-4380-9_37 · Cited by 26,297
(2008) · The Concise Encyclopedia of Statistics · doi:10.1007/978-0-387-32833-1_5 · Cited by 2,670
Goodman, J. L., Winston, D. J., Greenfield, R. A., Chandrasekar, P. H., Fox, B., Kaizer, H., Shadduck, R. K., Shea, T. C., Stiff, P., Friedman, D. J., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199203263261301 · Cited by 1,174 · cited 1×
“However, this phenomenon has not been confirmed in large prospective studies [26-29].”
ResultSecular Trends in the Epidemiology of Nosocomial Fungal Infections in the United States, 1980-1990
Sague, C. M. B., Jarvis, W. R., & System, N. N. I. S. (1993) · Journal of Infectious Diseases · doi:10.1093/infdis/167.5.1247 · Cited by 1,140
Rex, J. H., Bennett, J. E., Sugar, A. M., Pappas, P. G., van der Horst, C. M., Edwards, J. E., Washburn, R. G., Scheld, W. M., Karchmer, A. W., Dine, A. P., et al. (1994) · New England Journal of Medicine · doi:10.1056/nejm199411173312001 · Cited by 1,039
Wingard, J. R., Merz, W. G., Rinaldi, M. G., Johnson, T. R., Karp, J. E., & Saral, R. (1991) · New England Journal of Medicine · doi:10.1056/nejm199110313251803 · Cited by 937 · cited 1×
“glabrata) in patients receiving fluconazole [23-25].”
Resistance of Candida species to fluconazole
Rex, J. H., Rinaldi, M. G., & Pfaller, M. A. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.1.1 · Cited by 877 · cited 1×
“glabrata) in patients receiving fluconazole [23-25].”
The changing face of candidemia: emergence of non-Candida albicans species and antifungal resistance
Hong Nguyen, M., Peacock, J. E., Morris, A. J., Tanner, D. C., Nguyen, M. L., Snydman, D. R., Wagener, M. M., Rinaldi, M. G., & Yu, V. L. (1996) · The American Journal of Medicine · doi:10.1016/s0002-9343(95)00010-0 · Cited by 758 · cited 1×
“given about the patients' predisposing conditions [15].”
Survival Analysis: A Practical Approach.
Smith, P. J., Parmar, M. K. B., & David, M. (1996) · Journal of the American Statistical Association · doi:10.2307/2291609 · Cited by 730
Candidemia in a tertiary care hospital: epidemiology, risk factors, and predictors of mortality.
Fraser, V. J., Jones, M., Dunkel, J., Storfer, S., Medoff, G., & Dunagan, W. C. (1992) · Clinical Infectious Diseases · doi:10.1093/clind/15.3.414 · Cited by 679 · cited 2×
“glabrata [3, 4, 1522].”
Background
Cited by
Items 401–500 of 647
High-Risk Neutropenic Fever and Invasive Fungal Diseases in Patients with Hematological Malignancies
Mori, G., Diotallevi, S., Farina, F., Lolatto, R., Galli, L., Chiurlo, M., Acerbis, A., Xue, E., Clerici, D. T., Mastaglio, S., et al. (2024) · Microorganisms · doi:10.3390/microorganisms12010117 · Cited by 14
Testore, G. P., Dori, L., Buonomini, A. R., Schito, G. C., Soro, O., Fortina, G., Andreoni, S., Carlone, N. A., Tullio, V. C., & Andreoni, M. (2004) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2004.07.010 · Cited by 14
Liu, X., Zhou, W., Jiang, Y., & Kuang, L. (2018) · Japanese Journal of Infectious Diseases · doi:10.7883/yoken.jjid.2018.351 · Cited by 14
“clavatum infection are more susceptible to invasive organ infection (13) and amphotericin B can accumulate to high concentrations in the lung, liver, and spleen (14).”
BackgroundWu, J., Gan, C., Li, J., Liu, Y., Chen, Z., Zhang, Y., Yi, G., Sui, J., & Xu, J. (2021) · Infection and Drug Resistance · doi:10.2147/idr.s316368 · Cited by 14
Invasive fungal infection in children undergoing chemotherapy for cancer
Yeh, T., Liu, H., Wang, L.-Y., Chen, S., & Liang, D. (2007) · Annals of Tropical Paediatrics · doi:10.1179/146532807x192516 · Cited by 14
Coste, A., Linas, M. D., Cassaing, S., Bernad, J., Chalmeton, S., Séguéla, J. P., & Pipy, B. (2002) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkf011 · Cited by 14
Oral nystatin as antifungal prophylaxis in critically ill patients: an old SDD tool to be renewed?
Eggimann, P., Wolff, M., & Garbino, J. (2005) · Intensive Care Medicine · doi:10.1007/s00134-005-2806-y · Cited by 14
“However, antifungal prophylaxis has been repeatedly implicated in the increasing proportion of non-albicans Candida isolated in many cancer centers [10, 11].”
BackgroundSpruijtenburg, B., Meijer, E. F. J., Xiao, M., Shawky, S. M., Meis, J. F. G. M., de Groot, T., & El‐Kholy, M. A. (2023) · Journal of Global Antimicrobial Resistance · doi:10.1016/j.jgar.2023.06.012 · Cited by 13
Efficacy of Posaconazole in a Murine Disseminated Infection by Can dida tropicalis
Mariné, M., Pastor, F. J., & Guarro, J. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01136-09 · Cited by 13
“albicans (7), it has been associated with higher mortality rates in cancer patients (15).”
BackgroundShah, A., Ganesan, P., Radhakrishnan, V. S., Kannan, K., Rajendranath, R., Mahajan, V., Vijayakumar, V., Ganesan, T. S., & Sagar, T. G. (2016) · Indian Journal of Medical and Paediatric Oncology · doi:10.4103/0971-5851.177032 · Cited by 13
“[1] Up to a quarter of patients develop IFI during induction therapy of AML with an associated mortality of 40% (candidiasis and aspergillosis) to 70% (fusariosis and zygomycosis).[2-9] One of the reasons for the high mortality could be the difficulty in establishing the diagnosis and the consequent delay in instituti…”
BackgroundChandrasekar, P. H., Sirohi, B., Seibel, N. L., Hsu, J. W., Azie, N. E., Wu, C., & Ruhnke, M. (2018) · Mycoses · doi:10.1111/myc.12748 · Cited by 13
Candidoses et levuroses diverses
Develoux, M., & Bretagne, S. (2005) · EMC-Maladies infectieuses/Encyclopédie médico-chirurgicale. Maladies infectieuses · doi:10.1016/s1166-8598(05)26088-x · Cited by 13
Skepticism: A Lost Clinical Art
DiNubile, M. J. (2000) · Clinical Infectious Diseases · doi:10.1086/313945 · Cited by 13
“Perhaps a more aggressive approach to fungal superinfections is warranted in this high-risk setting, but we need to acknowledge that candidemia and/or visceral candidiasis might simply be markers for the sickest of the sick [68, 69].”
BackgroundInfection in the neutropenic and haematopoietic stem cell transplant recipient
Donnelly, J. P. (2000) · Current Opinion in Infectious Diseases · doi:10.1097/00001432-200008000-00002 · Cited by 13
Duan, Z., Chen, Q., Zeng, R., Du, L., Liu, C., Chen, X., & Li, M. (2018) · Canadian Journal of Microbiology · doi:10.1139/cjm-2017-0559 · Cited by 12
“Cancer, diabetes, older patients, long periods in the intensive care unit (ICU), 50 antibiotic administration and invasive surgery are highly related to the pathogenicity of 51 this organism (Negri et al. 2012; Nucci et al. 2010; Viscoli et al. 1999).”
BackgroundUpdate: invasive Pilzinfektionen
Lichtenstern, C., Swoboda, S., Hirschburger, M., Domann, E., Hoppe‐Tichy, T., Winkler, M., Lass‐Flörl, C., & Weigand, M. A. (2010) · Der Anaesthesist · doi:10.1007/s00101-009-1655-4 · Cited by 12
Treatment of candidiasis: insights from host genetics
Delsing, C. E., Bleeker‐Rovers, C. P., Kullberg, B. J., & Netea, M. G. (2012) · Expert Review of Anti-infective Therapy · doi:10.1586/eri.12.79 · Cited by 12
Kennedy, H., Shankland, G. S., Bagg, J., Chalmers, E. A., Gibson, B. E. S., & Williams, C. (2006) · Mycoses · doi:10.1111/j.1439-0507.2006.01272.x · Cited by 12
JSMM Clinical Practice Guidelines for Diagnosis and Treatment of Invasive Candidiasis
(2013) · Medical Mycology Journal · doi:10.3314/mmj.54.147 · Cited by 12
Opportunistic Pathogenic Yeasts
Banerjee, U. (2009) · Springer eBooks · doi:10.1007/978-1-4020-8292-4_11 · Cited by 12
Risk factors and outcome for breakthrough candidaemia in patients with cancer
Chung, J., Lee, S., Choi, S., Woo, J., Ryu, J., Kim, Y. S., & Kim, N. J. (2006) · Mycoses · doi:10.1111/j.1439-0507.2006.01198.x · Cited by 12
Espectro y factores de riesgo de la infección fúngica invasora
Castón, J. J., Román, A. R., & Torre‐Cisneros, J. (2007) · Enfermedades Infecciosas y Microbiología Clínica · doi:10.1157/13108710 · Cited by 12
Hayes‐Lattin, B., & Maziarz, R. T. (2003) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428190310001625719 · Cited by 12
Does One Voriconazole Breakpoint Suit All Candida Species?
Arendrup, M. C., Denning, D. W., Pfaller, M. A., Diekema, D. J., & Rex, J. H. (2007) · Journal of Clinical Microbiology · doi:10.1128/jcm.00412-07 · Cited by 12
Kang, K., Lee, B., Jeon, M. J., Yu, E. S., Kim, D. S., Lee, S. R., Sung, H. J., Choi, C. W., Park, Y., & Kim, B. S. (2020) · Therapeutic Advances in Hematology · doi:10.1177/2040620720966882 · Cited by 11
Epidemiología de candidemia en Córdoba. Estudio de vigilancia de cinco instituciones
Riera, F. O., Medeot, M., Sartori, L., Bergallo, C., Minoli, J., Vilchez, V., Sánchez, P., Abiega, C., Pincheira, C., Correa, S., et al. (2014) · Revista de la Facultad de Ciencias Médicas de Córdoba · doi:10.31053/1853.0605.v71.n2.9074 · Cited by 11
Diagnosis and Treatment of Invasive Fungal Infections Focus on Liposomal Amphotericin B
de Lacerda, J. F., & Meneses-Oliveira, C. (2013) · Clinical Drug Investigation · doi:10.1007/s40261-012-0023-3 · Cited by 11
“The alarming mortality rate of candidemia may be, at least partly, caused by the increasing incidence of non albicans species such Candida glabrata, Candida parapsilosis and Candida tropicalis [70].”
BackgroundSONMEZ, A., Ekşi, F., Pehlıvan, M., & Şahin, H. H. (2015) · Biomolecules and Biomedicine · doi:10.17305/bjbms.2015.409 · Cited by 11
“50% with Candida infections [3], and 100% with Aspergillus infections [4].”
BackgroundCheikh, J. E., Crocchiolo, R., Vai, A., Furst, S., Bramanti, S., Sarina, B., Granata, A., Faucher, C., Mohty, B., Harbi, S., et al. (2015) · Mediterranean Journal of Hematology and Infectious Diseases · doi:10.4084/mjhid.2015.048 · Cited by 11
Smyth, J., Mullen, C. G., Jack, L., Collier, A., & Bal, A. M. (2018) · Journal de Mycologie Médicale · doi:10.1016/j.mycmed.2018.05.004 · Cited by 11
Characteristics of late recurrent candidemia in adult patients
Ala‐Houhala, M., & Anttila, V. (2020) · Mycoses · doi:10.1111/myc.13236 · Cited by 11
“856 Admitted to ICU after onset of candidemia 0 27 (9) .”
BackgroundSafdar, A., Armstrong, D., Cross, E. W., & Perlin, D. S. (2002) · International Journal of Infectious Diseases · doi:10.1016/s1201-9712(02)90111-6 · Cited by 10
Trends in fungaemia and antifungal susceptibility in the Netherlands.
Lunel, F. M. V., Koeleman, J. G. M., Spanjaard, L., Vandenbroucke‐Grauls, C. M. J. E., Schultz, C., Verbrugh, H. A., Vos, G., Troelstra, A., Mascini, E. M., Verweij, P. E., et al. (2006) · PubMed · Cited by 11
Krcmery, V. (2005) · Medical Principles and Practice · doi:10.1159/000084627 · Cited by 11
Self-citationBaere, T. D., Keerberghen, A. V., Hauwe, P. V., Beenhouwer, H. D., Boel, A., Verschraegen, G., Claeys, G., & Vaneechoutte, M. (2005) · BMC Microbiology · doi:10.1186/1471-2180-5-14 · Cited by 11
“Whereas Candida albicans has long been considered as the clinically most important species of the genus, the occurrence and pathogenic importance of the non-albicans species has been increasing steadily [2].”
BackgroundEpidemiology of adult candidemia at Chiang Mai University Hospital.
Chaiwarith, R., Ounbang, P., Khamwan, C., Nuntachit, N., Sirisanthana, T., & Supparatpinyo, K. (2011) · PubMed · Cited by 10
Invasive fungal infection in children with hematologic malignancy
Gülhan, B., Yüksek, S. K., Parlakay, A. Ö., Yaralı, N., Tezer, H., & Özbek, N. Y. (2019) · The Turkish Journal of Pediatrics · doi:10.24953/turkjped.2019.02.002 · Cited by 10
When and How to Cover for Fungal Infections in Patients with Severe Sepsis and Septic Shock
Allou, N., Allyn, J., & Montravers, P. (2011) · Current Infectious Disease Reports · doi:10.1007/s11908-011-0204-x · Cited by 10
“infections, and Viscoli et al. [ 12 ] reported 10% of septic shock among 249 episodes of candidemia.”
BackgroundRisks and outcome of fungal infection in neutropenic children with hematologic diseases.
Aytaç, S., Yildirim, I. B., Ceyhan, M., Cetin, M., Tuncer, M. A., Kara, A., Cengiz, A. B., Secmeer, G., & Yetgin, S. (2010) · PubMed · Cited by 10
Zabalza, A., Gorosquieta, A., Equiza, E. P., & Olavarría, E. (2013) · Therapeutic Advances in Hematology · doi:10.1177/2040620713481796 · Cited by 10
Achievements and goals of the EORTC Invasive Fungal Infections Group
Pauw, B. E. D., Herbrecht, R., & Meunier, F. (2002) · European Journal of Cancer · doi:10.1016/s0959-8049(01)00460-9 · Cited by 10
Self-citationInvasive Candidiasis in Patients with Solid Tumors: A Single-Center Retrospective Study
Bai, X., & Luo, J. (2023) · International Journal of General Medicine · doi:10.2147/ijgm.s411006 · Cited by 9
“In a study in Europe, the mortality rate of patients with invasive candidiasis associated with cancer was 39%.(30) Our data shows that the mortality rate of patients with solid tumors accompanied by invasive candidiasis is 13.”
BackgroundManagement of Acute Myeloid Leukemia in the Intensive Care Setting
Cowan, A. J., Altemeier, W. A., Johnston, C., Gernsheimer, T., & Becker, P. S. (2014) · Journal of Intensive Care Medicine · doi:10.1177/0885066614530959 · Cited by 9
“Patients with neutropenia having AML are also at high risk of candidemia, which may present with septic shock in 10% of cases.(70) Although antifungal prophylaxis is used during neutropenia, breakthrough candidemias account for nearly half of the candidemias in patients with leukemia.”
BackgroundVoriconazole prophylaxis in leukemic patients: A retrospective single-center study
Bui, V., Walker, S. A. N., Elligsen, M., Vyas, A., Kiss, A., & Palmay, L. (2019) · Journal of Oncology Pharmacy Practice · doi:10.1177/1078155219876683 · Cited by 9
Rosa, F. G. D., Busca, A., Capparella, M. R., Yan, J. L., & Aram, J. A. (2021) · Clinical Drug Investigation · doi:10.1007/s40261-021-01024-7 · Cited by 9
“In addition to older age and advanced disease, surgery, admission to the intensive care unit (ICU), and invasive procedures were factors associated with 30-day mortality [5, 7, 9, 10].”
BackgroundCandida Colonization Index in the Management of Critically III Patients
Eggimann, P., & Pittet, D. (2006) · Yearbook of intensive care and emergency medicine · doi:10.1007/3-540-33396-7_56 · Cited by 9
Empiric antifungal therapy in neutropenic cancer patients
Rotstein, C. (2006) · Current Infectious Disease Reports · doi:10.1007/s11908-006-0029-1 · Cited by 9
Epidemiology of candidemia at a tertiary Canadian hospital, 2004–2013
Remington, T. L., Isaac, A., Vickers, D., Fuller, J., & Smith, S. W. (2018) · Journal of the Association of Medical Microbiology and Infectious Disease Canada · doi:10.3138/jammi.3.1.04 · Cited by 8
Blot, F. (2003) · Réanimation · doi:10.1016/s1624-0693(03)00048-3 · Cited by 8
Clinical Syndromes: Candida and Candidosis
Ruhnke, M. (2018) · Springer eBooks · doi:10.1007/978-3-319-92300-0_4 · Cited by 8
Recomendaciones para el manejo de la candidemia en adultos en América Latina
Nucci, M., Thompson-Moya, L., Guzmán-Blanco, M., Tiraboschi, I. N., Cortés, J. A., Echevarria, J. I., Sifuentes‐Osornio, J., Zurita, J., Santolaya, M. E., Matute, T. A., et al. (2013) · Revista Iberoamericana de Micología · doi:10.1016/j.riam.2013.06.001 · Cited by 8
Infections candidosiques sévères chez le patient neutropénique en onco-hématologie pédiatrique
Pellegrinoa, B., Guyader, N. L., Thien, H. V., Fasola, S., Auvrignon, A., & Leverger, G. (2003) · Archives de Pédiatrie · doi:10.1016/s0929-693x(03)90040-6 · Cited by 8
Mariné, M., Espada, R., Torrado, J. J., Pastor, F., & Guarro, J. (2009) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2009.07.005 · Cited by 8
Isolation of fungal flora from the hair coats of clinically healthy dogs and cats.
Ivaškienė, M., Šiugždaitė, J., Matusevičius, A.-P., Grigonis, A., Zamokas, G., & Špakauskas, V. (2009) · Lithuanian University of Health Sciences · Cited by 8
Echinocandins: A promising new antifungal group
Randhawa, G. K., & Sharma, G. (2004) · Indian Journal of Pharmacology · Cited by 8
Salih, Z., Cavet, J., Dennis, M., Somervaille, T. C. P., Bloor, A. J. C., & Kulkarni, S. (2013) · South Asian Journal of Cancer · doi:10.4103/2278-330x.119920 · Cited by 8
“Some of the well‐established risk factors include use of central venous access device (CVD),[3] prolonged antibiotic use,[4] nature of underlying malignancy,[5] intensity of treatment,[6] duration of neutropenia, intensity of neutropenia,[7,8] comorbidities, breakage of mucosal barriers,[9,10] and use of corticosteroi…”
BackgroundAlışkan, H. E., Ersözlü, E. D., Çolakoğlu, Ş., & Demirbilek, M. (2016) · Turkish Bulletin of Hygiene and Experimental Biology · doi:10.5505/turkhijyen.2016.49369 · Cited by 8
Dutta, S., Panda, S. K., & Dubey, D. (2010) · International Journal of Green Pharmacy · doi:10.4103/0973-8258.63885 · Cited by 8
“albicans.[24] The noticeable increase in the frequency of infections caused by non-albicans Candida species and the appearance of candidal isolates resistant to both amphotericin B and the newer azoles represent two important alterations in the pattern of Candida infections.”
BackgroundUnusual infections and novel therapy in the immunocompromised host
Gilleece, A. C., & Fenelon, L. E. (2000) · Current Opinion in Infectious Diseases · doi:10.1097/00001432-200008000-00006 · Cited by 8
Fasciana, T., Giuffrè, M., Calà, C., Schierz, I. A. M., Aquilina, G., Pinello, G., Capra, G., Lipari, D., Corsello, G., & Giammanco, A. (2017) · Advances in experimental medicine and biology · doi:10.1007/5584_2016_195 · Cited by 7
Almeida, B., Breda, G. L., Queiroz‐Telles, F., & Tuon, F. F. (2014) · Scandinavian Journal of Infectious Diseases · doi:10.3109/00365548.2014.952246 · Cited by 7
Trad, O., Jumaa, P., & Afify, Z. (2003) · Pediatric Hematology and Oncology · doi:10.1080/08880010390203044 · Cited by 7
Arzneimitteltherapie invasiver Candida- und Aspergillusinfektionen
Maschmeyer, G., & Ruhnke, M. (2002) · Der Internist · doi:10.1007/s00108-002-0713-7 · Cited by 7
Guidelines for the Management of Deep Mycosis in Neutropenic Patients
Yoshida, M. (2004) · Nippon Ishinkin Gakkai Zasshi · doi:10.3314/jjmm.45.209 · Cited by 7
Chapter 5 Differences in stress responses between model and pathogenic fungi
(2008) · The British Mycological Society symposium series · doi:10.1016/s0275-0287(08)80047-1 · Cited by 6
Tellería, O., Ezpeleta, G., Herrero, O., Miranda-Zapico, I., Quindós, G., & Cisterna, R. (2012) · Journal of Chromatography B · doi:10.1016/j.jchromb.2012.03.007 · Cited by 6
Candidaemia in Patients with Haematological Disorders and Stem Cell Transplant
Al‐Anazi, K. A., & Al-Jasser, A. M. (2006) · Libyan Journal of Medicine · doi:10.3402/ljm.v1i2.4673 · Cited by 6
Yenişehirli, G., Özveren, G., Yenişehirli, A., & Bulut, Y. (2018) · Jundishapur Journal of Microbiology · doi:10.5812/jjm.59404 · Cited by 6
“Prophylactic and therapeutic uses of antifungal agents have given rise to a significant shift to more resistant non-albicans Candida species associated with fungal infections (1-4).”
BackgroundKrcmery, V. (2000) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(00)00295-8 · Cited by 6
Self-citationNew enzymatic method for determiningD-arabinitol in serum
Hino, M., Tatsumi, N., Yamane, T., Ohta, K., Takubo, T., & Yabuuchi, M. (2000) · Journal of Basic Microbiology · doi:10.1002/1521-4028(200012)40:5/6<363::aid-jobm363>3.0.co;2-e · Cited by 6
“Improvements in the management of bacterial infections can lead to an increased frequency of fungal infections among immunosupressed hosts such as cancer patients and transplant recipients (VISCOLI et al. 1999).”
BackgroundCornely, O. A., Pels, H., Bethe, U., Seibold, M., Toepelt, K., Söhngen, D., & Ritzkowsky, A. (2001) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1703250 · Cited by 6
The Contribution Of Growth Rate To The Pathogenicity Of Candida Spp.
Pang, S.-Y. M., Tristram, S. G., & Brown, S. B. (2011) · Zenodo (CERN European Organization for Nuclear Research) · doi:10.5281/zenodo.1057494 · Cited by 5
Lehmann, D. M., Cohen, N., Lin, I., Alexander, S., Kathuria, R., Kerpelev, M., Taur, Y., & Seo, S. K. (2022) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofac555 · Cited by 5
“Both persisting neutropenia and advanced malignancy also happen to be adverse prognostic factors for mortality in cancer patients with candidemia [1, 23].”
BackgroundSerum IgG against Candida predict survival in patients with metastatic renal cell carcinoma
Ramoner, R. E., Rahm, A., Falkensammer, C. E., Leonhartsberger, N., & Thurnher, M. (2010) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-010-0827-z · Cited by 5
“In hematologic malignancies, candidemia is frequently associated with poor prognosis and increase in mortality [10] but little is known about the role of Candida in the development and progression of solid tumors.”
BackgroundSchulz, B., Knobloch, M., Moran, G. P., Weber, K., & Ruhnke, M. (2012) · Medical Mycology · doi:10.3109/13693786.2011.608730 · Cited by 5
Yoğurtçu, B. M., Demirci, S., Doğan, A., Asutay, A. B., & Şahin, F. (2017) · World Journal of Microbiology and Biotechnology · doi:10.1007/s11274-017-2368-5 · Cited by 5
Olajuyigbe, O. O., Adeoye-Isijola, M. O., & Coopoosamy, R. M. (2019) · Kragujevac Journal of Science · doi:10.5937/kgjsci1941087o · Cited by 5
Seyedmousavi, S., İlkit, M., Durdu, M., Ergin, Ç., Polat, S. H., Melchers, W. J. G., & Verweij, P. E. (2015) · Türk Mikrobiyoloji Cemiyeti Dergisi · doi:10.5222/tmcd.2015.001 · Cited by 5
Infectious Complications of Cancer Therapy
Safdar, N., Crnich, C. J., & Maki, D. G. (2006) · Springer eBooks · doi:10.1007/0-387-31056-8_76 · Cited by 5
“are also an increasingly common cause of nosocomial BSI,(166) associated with case-fatality rates ranging from 30% to 60%.(167,168) Disseminated infection usually occurs as a complication of candidemia and may be associated with cutaneous lesions, retinitis or endophthalmitis, osteomyelitis, and even endocarditis.”
BackgroundParlakay, A. Ö., Ozer-Bekmez, B., Kara, A., Kuşkonmaz, B., Akçören, Z., Arikan-Dagli, S., & Oguz, B. S. (2013) · Pediatrics & Neonatology · doi:10.1016/j.pedneo.2013.09.010 · Cited by 5
Morichika, D., Hisamoto, A., Hotta, K., Takata, K., Iwaki, N., Uchida, K., Minami, D., Kubo, T., Tanimoto, M., & Kiura, K. (2014) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/hyu019 · Cited by 5
Nosocomial Candida infections: epidemiology of candidaemia
Gallé, F., Catania, M. R., & Liguori, G. (2006) · Journal of preventive medicine and hygiene · doi:10.15167/2421-4248/jpmh2006.47.3.78 · Cited by 5
Current evidence for the treatment of invasive fungal infections in immunocompromised patients
Auberger, J., & Lass‐Flörl, C. (2011) · Clinical Investigation · doi:10.4155/cli.11.5 · Cited by 4
ANTICANDIDAL ACTIVITY OF CROTON ROXBURGHII BALAK
Panda, S. K., Bastia, A. K., & Dutta, S. K. (2010) · Cited by 4
Managing invasive fungal infections during allogeneic hematopoietic transplantation: A 2025 Update
Quattrone, M., Pilla, A. D., Brunetti, S., Giordano, A., Fianchi, L., Pagano, L., & Criscuolo, M. (2025) · Mediterranean Journal of Hematology and Infectious Diseases · doi:10.4084/mjhid.2025.064 · Cited by 4
Prevalence of Oral Candidiasis among Children Caused by Different Candida Species
Rawnuck, T., Reza, M. S., Ahmed, R., Islam, M. F. U., Hossain, A. I., Sultana, N., & Monwar, S. (2022) · Medicine Today · doi:10.3329/medtoday.v34i1.58678 · Cited by 4
Khemani, P., Srinivasan, S., Salunke, G. V., Prasad, M., Dhamne, C. A., Parambil, B. C., Chichra, A., Gollamudi, V. R. M., Sunder, I. R., Moulik, N. R., et al. (2024) · Journal de Mycologie Médicale · doi:10.1016/j.mycmed.2024.101510 · Cited by 4
Diagnosis and Management of Fungal Urinary Tract Infections
Ritchie, T., & Eltahawy, E. A. (2014) · Current Bladder Dysfunction Reports · doi:10.1007/s11884-014-0238-7 · Cited by 4
Strand, A. M., Alexander, B. D., Sarpong, E., Wong, J. R., Engemann, A. K., Rizzieri, D. A., Wu, Y. S., & Johnson, M. D. (2022) · Mycoses · doi:10.1111/myc.13495 · Cited by 4
Etiology of candidemia in patients with solid tumors - 7 years of experience of one oncology center
Szymankiewicz, M., & Nowikiewicz, T. (2020) · Neoplasma · doi:10.4149/neo_2020_200204n105 · Cited by 4
Infection With Saprochaete Clavata in Children After Hematopoietic Cell Transplantation
Styczyński, T., Sadlok, J., Richert-Przygońska, M., Dębski, R., Zalas‐Więcek, P., Czyźewski, K., & Styczyński, J. (2023) · Journal of Pediatric Hematology/Oncology · doi:10.1097/mph.0000000000002686 · Cited by 4
Invasive Fungal Infections in Patients with Acute Leukemia
Hsiao, H., Tsai, H., Liu, Y., Tseng, Y., Lu, P., Yang, W., Liu, T., & Lin, S. (2006) · The Kaohsiung Journal of Medical Sciences · doi:10.1016/s1607-551x(09)70239-6 · Cited by 4
“Although there has been some improvement in the management of fungal infection, successful therapy of invasive fungal infection still relies on early recognition of the infection, proper initiation of antifungal therapy, and improvement of the underlying neutropenic status [6, 8,11].”
BackgroundYang, T., Li, W., Li, Y., Liu, X., & Yang, D. (2020) · Mycopathologia · doi:10.1007/s11046-020-00442-z · Cited by 4
Chronic mucocutaneous candidiasis: a spectrum of genetic disorders
Nahum, A. (2017) · LymphoSign Journal · doi:10.14785/lymphosign-2017-0011 · Cited by 4
Managing the challenges of invasive fungal infections
Herbrecht, R. (2006) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2006.03.002 · Cited by 4
Use of antifungal agents in the intensive care unit
Gottfreðsson, M., & Perfect, J. R. (1999) · Current Opinion in Critical Care · doi:10.1097/00075198-199910000-00008 · Cited by 4
Transcriptional Regulation of Azole Antifungal Resistance and Tolerance in Candida Glabrata
Caudle, K. E. (2010) · doi:10.21007/etd.cghs.2010.0045 · Cited by 4
Recherche de biofilms mixtes sur cathéters veineux périphériques au CHU de Tlemcen
Seghir, A. (2016) · Dépôt Institutionnel de lUniversité de Tlemcen · Cited by 4
Metadata
- Authors
- Viscoli, C., Girmenia, C., Marinus, A., Collette, L., Martino, P., Vandercam, B., Doyen, C., Lebeau, B., Spence, D., Krcmery, V., De Pauw, B., Meunier, F., & the Invasive Fungal Infection Group of the EORTC
- Affiliations
- University of Genoa (IT)
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 1999-05
- Volume
- 28
- Issue
- 5
- Pages
- 1071-1079
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2126536749
- Cited by
- 601
- References
- 29
- Citations by year
- 2026: 2 · 2025: 2 · 2024: 5 · 2023: 11 · 2022: 6 · 2021: 9 · 2020: 9 · 2019: 8 · 2018: 16 · 2017: 15 · 2016: 16 · 2015: 22 · 2014: 27 · 2013: 31 · 2012: 25
- FWCI
- 21.24
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Infectious Diseases (publishedVersion)
- PubMed (publishedVersion)
- Digital Access to Libraries (Université catholique de Louvain (UCL), l'Université de Namur (UNamur) and the Université Saint-Louis (USL-B)) (submittedVersion)
- Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles) (submittedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Health Sciences › Medicine › Oncology › Neutropenia and Cancer Infections
- Health Sciences › Medicine › Infectious Diseases › Fungal Infections and Studies
- Keywords
- candidemia, invasive fungal infections, cancer patients, Candida albicans, non-albicans Candida, Candida glabrata, solid tumors, hematologic malignancies, acute leukemia, neutropenia, antifungal prophylaxis, allogeneic bone marrow transplantation, septic shock, 30-day mortality, risk factors
- MeSH terms
- Adult, Aged, Aged, 80 and over, Candida albicans, Candidiasis, Child, Child, Preschool, Cross Infection, Female, Humans, Male, Middle Aged, Neoplasms, Neutropenia, Population Surveillance, Prospective Studies, Multivariate Analysis, Survival Analysis, Hematologic Neoplasms
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.